Provided by Tiger Fintech (Singapore) Pte. Ltd.

Orchestra BioMed

2.92
-0.1100-3.63%
Post-market: 2.940.0200+0.68%19:52 EDT
Volume:91.79K
Turnover:269.42K
Market Cap:111.87M
PE:-1.65
High:3.04
Open:3.04
Low:2.90
Close:3.03
Loading ...

Orchestra BioMed Holdings Is Maintained at Buy by Chardan Capital

Dow Jones
·
23 Apr

Orchestra BioMed Says AVIM Therapy Gets US FDA Breakthrough Device Designation

MT Newswires Live
·
22 Apr

Orchestra Biomed Holdings Shares up 9% on FDA's Fast Track Tag for Blood Pressure Therapy

THOMSON REUTERS
·
22 Apr

Orchestra BioMed Shares Rally After FDA Breakthrough Approval for Blood-Pressure Device

Dow Jones
·
22 Apr

BRIEF-Orchestra Biomed Receives FDA Breakthrough Device Designation For Avim Therapy

Reuters
·
22 Apr

Orchestra Biomed Receives FDA Breakthrough Device Designation for Avim Therapy

THOMSON REUTERS
·
22 Apr

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

GlobeNewswire
·
22 Apr

Orchestra BioMed’s Strategic Advances in Medical Innovations

TIPRANKS
·
08 Apr

Orchestra BioMed Holdings Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
04 Apr

Orchestra Biomed Holdings, Inc. : H.c. Wainwright Cuts Target Price to $12 From $14

THOMSON REUTERS
·
04 Apr

Orchestra BioMed Holdings Full Year 2024 Earnings: Revenues Disappoint

Simply Wall St.
·
02 Apr

Orchestra BioMed Holdings Is Maintained at Buy by Chardan Capital

Dow Jones
·
02 Apr

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

GlobeNewswire
·
01 Apr

Freightos And 2 Other Penny Stocks Worth Watching

Simply Wall St.
·
25 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Orchestra BioMed Holdings Initiated at Buy by BTIG

Dow Jones
·
20 Mar

BTIG Initiates Orchestra BioMed at Buy With $12 Price Target

MT Newswires Live
·
20 Mar

Orchestra Biomed Holdings Inc : Btig Initiates Coverage With Buy Rating; Price Target $12

THOMSON REUTERS
·
20 Mar

Orchestra BioMed Holdings Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Mar

Orchestra BioMed Highlights Strategic Initiatives and Innovations

TIPRANKS
·
03 Mar